Primary Site >> Colorectal Cancer
Gene >> FBXO32
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|
|
Ref: Anticatabolic effects of avoiding preoperative fasting by intravenous hypocaloric nutrition: a randomized clinical trial. PMID: 19092350 |
Ref: Parthenolide from Parthenium integrifolium reduces tumor burden and alleviate cachexia symptoms in the murine CT-26 model of colorectal carcinoma. PMID: 23746953 |
Ref: Myostatin gene inactivation prevents skeletal muscle wasting in cancer. PMID: 25336187 |
Ref: Muscle-specific E3 ubiquitin ligases are involved in muscle atrophy of cancer cachexia: an in vitro and in vivo study. PMID: 25760630 Ref: Inhibition of Stat3 activation suppresses caspase-3 and the ubiquitin-proteasome system, leading to preservation of muscle mass in cancer cachexia. PMID: 25787076 |
Ref: Antioxidant supplementation accelerates cachexia development by promoting tumor growth in C26 tumor-bearing mice. PMID: 26708754 Ref: The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia. PMID: 27929469 |
Ref: Oral Treatment with the Ghrelin Receptor Agonist HM01 Attenuates Cachexia in Mice Bearing Colon-26 (C26) Tumors. PMID: 28475119 Ref: Canadine from Corydalis turtschaninovii Stimulates Myoblast Differentiation and Protects against Myotube Atrophy. PMID: 29258243 |
Ref: Preliminary Study of the Role F-Box Protein 32 (FBXO32) in Colorectal Neoplasms Through the Transforming Growth Factor beta (TGF-beta)/Smad4 Signalling Pathway. PMID: 29465067 |